Cash flow Nectar Lifesciences Limited

Stocks

NECLIFE

INE023H01027

Pharmaceuticals

Delayed NSE India S.E. 03:48:44 2026-09-15 EDT			5-day change	1st Jan Change
11.78 ^INR	+2.43%		-3.05%	-39.31%

08-15	Nectar Lifesciences Limited Changes Its Corporate Office in Chandigarh	CI
08-14	Nectar Lifesciences Limited Announces Board and Committee Changes, Effective August 14, 2026	CI

b60606f5759087f18.UAp3f-NhqNRMrVjyhhr2Xwr-RfHbhv6RE83GEEOE-sA.M30yUoA-6uIUyBG41S2eKnqqPMCp0M3IUJ6pdg6yy_M6bi86uVX3rDjKNw

Published financial data: NECTAR LIFESCIENCES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	16.69B	15.24B	16.84B	16.7B	-
Other Revenues, Total	250K	240K	250K	3.92M	-
Total Revenues	16.69B	15.24B	16.84B	16.7B	-
Cost of Goods Sold, Total	12.23B	11.59B	12.02B	13.88B	-
Gross Profit	4.46B	3.64B	4.82B	2.82B	-
Selling General & Admin Expenses, Total	763M	796M	866M	985M	29.44M
Provision for Bad Debts	-	-	-	-	1.24M
Depreciation & Amortization - (IS)	570M	591M	607M	624M	3.43M
Other Operating Expenses	2.11B	2.31B	2.42B	2.09B	1.08B
Other Operating Expenses, Total	3.44B	3.7B	3.89B	3.7B	1.11B
Operating Income	1.02B	-51.73M	924M	-885M	-1.11B
Interest Expense, Total	-699M	-828M	-896M	-771M	-1.47M
Interest And Investment Income	18.84M	17.26M	124M	14.89M	70.4M
Net Interest Expenses	-681M	-811M	-772M	-756M	68.93M
Currency Exchange Gains (Loss)	4.68M	98.78M	97.5M	385M	-360M
Other Non Operating Income (Expenses)	-93.34M	-65.66M	-68.09M	-361M	2.4M
EBT, Excl. Unusual Items	247M	-829M	181M	-1.62B	-1.4B
Gain (Loss) On Sale Of Investments	30K	1.05M	1.8M	350K	521M
Gain (Loss) On Sale Of Assets	94.07M	404M	-	-140K	1.6M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	341M	-424M	183M	-1.62B	-879M
Income Tax Expense	90.34M	-182M	133M	-479M	-305M
Earnings From Continuing Operations	250M	-242M	49.95M	-1.14B	-573M
Earnings Of Discontinued Operations	-	-	-	-	-2.36B
Net Income to Company	250M	-242M	49.95M	-1.14B	-2.93B
Net Income - (IS)	250M	-242M	49.95M	-1.14B	-2.93B
Net Income to Common Incl Extra Items	250M	-242M	49.95M	-1.14B	-2.93B
Net Income to Common Excl. Extra Items	250M	-242M	49.95M	-1.14B	-573M
Per Share Items
Net EPS - Basic	1.12	-1.08	0.22	-5.07	-13.4
Basic EPS - Continuing Operations	1.12	-1.08	0.22	-5.07	-2.62
Basic Weighted Average Shares Outstanding	224M	224M	224M	224M	219M
Net EPS - Diluted	1.12	-1.08	0.22	-5.07	-13.4
Diluted EPS - Continuing Operations	1.12	-1.08	0.22	-5.07	-2.62
Diluted Weighted Average Shares Outstanding	224M	224M	224M	224M	219M
Normalized Basic EPS	0.69	-2.31	0.5	-4.5	-4.01
Normalized Diluted EPS	0.69	-2.31	0.5	-4.5	-4.01
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	1.59B	539M	1.53B	-261M	-885M
EBITA	1.09B	38.37M	1.04B	-764M	-1.07B
EBIT	1.02B	-51.73M	924M	-885M	-1.11B
EBITDAR	1.6B	558M	1.55B	-240M	-876M
Total Revenues (As Reported)	16.8B	15.67B	16.99B	16.75B	92.91M
Effective Tax Rate - (Ratio)	26.51	42.99	72.66	29.62	34.74
Total Current Taxes	-	68.93M	64.15M	79.05M	72.79M
Total Deferred Taxes	90.34M	-251M	68.59M	-558M	-1.77B
Normalized Net Income	154M	-518M	113M	-1.01B	-876M
Non-Cash Pension Expense	6.39M	6.05M	8.06M	9.56M	300K
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	1.24M
Selling and Marketing Expenses	-	-	-	-	1.24M
Research And Development Expense From Footnotes	30.7M	26.54M	67.06M	85.51M	-
Net Rental Expense, Total	17.64M	18.3M	18.93M	20.35M	9.08M
Imputed Operating Lease Interest Expense	11.2M	15.02M	19.54M	20.61M	-
Imputed Operating Lease Depreciation	6.44M	3.28M	-608K	-256K	-
Maintenance & Repair Expenses, Total	-	-	-	205M	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	178M	176M	198M	192M	1.12B
Short Term Investments	4.6M	-	-	-	-
Trading Asset Securities, Total	-	3.14M	4.95M	5.3M	130M
Total Cash And Short Term Investments	183M	179M	203M	198M	1.25B
Accounts Receivable, Total	4.47B	2.8B	3.79B	3.45B	-
Other Receivables	671M	638M	423M	460M	726M
Notes Receivable	3.94M	3.73M	9.24M	8.57M	910K
Total Receivables	5.14B	3.44B	4.22B	3.92B	727M
Inventory	7.21B	7.32B	7.77B	7.42B	6.34M
Other Current Assets, Total	1.01B	1.38B	646M	832M	904M
Total Current Assets	13.55B	12.31B	12.84B	12.38B	2.89B
Gross Property Plant And Equipment	14.81B	14.54B	14.69B	14.96B	1.06B
Accumulated Depreciation	-7.16B	-7.63B	-8.13B	-8.63B	-24.6M
Net Property Plant And Equipment	7.65B	6.9B	6.56B	6.33B	1.03B
Long-term Investments	2.35M	2.35M	2.35M	2.35M	2.35M
Goodwill	-	-	-	-	11.12M
Other Intangibles, Total	430M	493M	524M	565M	-
Accounts Receivable Long-Term	78.28M	73.46M	81.54M	84.87M	-
Loans Receivable Long-Term	-	-	-	-	700K
Deferred Tax Assets Long-Term	28M	206M	74.78M	550M	2.24B
Other Long-Term Assets, Total	2.17B	1.9B	1.83B	560M	34.84M
Total Assets	23.91B	21.89B	21.91B	20.47B	6.22B
Liabilities
Accounts Payable, Total	3.77B	3.19B	4.2B	4.38B	-
Accrued Expenses, Total	120M	383M	154M	151M	6.58M
Short-term Borrowings	5.03B	4.59B	4.12B	4.4B	-
Current Portion of Long-Term Debt	661M	684M	830M	817M	-
Current Income Taxes Payable	-	-	-	-	-
Other Current Liabilities	463M	65.26M	426M	464M	295M
Total Current Liabilities	10.04B	8.91B	9.73B	10.22B	301M
Long-Term Debt	2.91B	2.26B	1.4B	601M	-
Unearned Revenue Non Current	7.96M	7.71M	7.46M	7.21M	-
Pension & Other Post Retirement Benefits	63.93M	64.46M	79.37M	87.28M	50K
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	8.3M	-	-10K	10K	91.92M
Total Liabilities	13.03B	11.25B	11.22B	10.91B	393M
Common Stock, Total	224M	224M	224M	224M	194M
Additional Paid In Capital	3.29B	3.29B	3.29B	3.29B	2.51B
Retained Earnings	7.37B	7.13B	7.18B	6.05B	3.12B
Comprehensive Income and Other	-	10K	-	-	-
Total Common Equity	10.88B	10.65B	10.69B	9.56B	5.82B
Total Equity	10.88B	10.65B	10.69B	9.56B	5.82B
Total Liabilities And Equity	23.91B	21.89B	21.91B	20.47B	6.22B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	224M	224M	224M	224M	194M
ECS Total Common Shares Outstanding	224M	224M	224M	224M	194M
Book Value / Share	48.51	47.47	47.68	42.63	29.97
Tangible Book Value	10.45B	10.15B	10.17B	9B	5.81B
Tangible Book Value Per Share	46.59	45.27	45.34	40.11	29.92
Total Debt	8.6B	7.54B	6.36B	5.82B	0
Net Debt	8.42B	7.36B	6.15B	5.62B	-1.25B
Debt Equivalent of Unfunded Proj. Benefit Obligation	80.91M	83.06M	102M	116M	3.62M
Debt Equivalent Oper. Leases	141M	146M	151M	163M	72.64M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	1.58B	1.2B	1.1B	820M	-
Inventories - Work In Process, Total	3.71B	5.16B	5.39B	5.72B	-
Inventories - Finished Goods, Total	1.13B	207M	458M	229M	-
Inventories - Others	175M	160M	142M	135M	2.98M
Land - (BS)	516M	192M	192M	192M	1B
Buildings, Total	1.77B	1.76B	1.8B	1.82B	7.27M
Machinery, Total	9.94B	10.01B	10.19B	10.45B	50.14M
Full Time Employees	1.67K	1.59K	1.69K	1.79K	111
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	250M	-242M	49.95M	-1.14B	-2.93B
Depreciation & Amortization - CF	491M	501M	494M	503M	184M
Amortization of Goodwill and Intangible Assets - (CF)	78.95M	90.1M	113M	121M	43.8M
Depreciation & Amortization, Total	570M	591M	607M	624M	228M
(Gain) Loss From Sale Of Asset	-94.07M	-404M	-	140K	1.52B
(Gain) Loss on Sale of Investments - (CF)	-30K	-1.05M	-1.8M	-350K	521M
Provision and Write-off of Bad Debts	9.65M	2.23M	9.33M	16.08M	-98.67M
Net Cash From Discontinued Operations	-	-	-	-	-7.01B
Other Operating Activities, Total	860M	611M	894M	272M	2.22B
Change In Accounts Receivable	-	-	-	-	3.16B
Change In Inventories	-	-	-	-	2.33B
Change In Accounts Payable	-	-	-	-	-3.42B
Change in Other Net Operating Assets	-645M	779M	689M	1.92B	-12.26M
Cash from Operations	950M	1.34B	2.25B	1.69B	-3.49B
Capital Expenditure	-250M	-301M	-294M	-438M	-123M
Sale of Property, Plant, and Equipment	397M	798M	-	80K	205M
Cash Acquisitions	-	-	-	-	32.37M
Divestitures	-	-	-	-	12.54B
Investment in Marketable and Equity Securities, Total	-	2.5M	-	-	-645M
Other Investing Activities, Total	18.83M	17.26M	124M	18.57M	72.79M
Cash from Investing	166M	517M	-170M	-419M	12.08B
Short Term Debt Issued, Total	-	-	-	280M	-
Long-Term Debt Issued, Total	1.57B	10K	4.12M	-	-
Total Debt Issued	1.57B	10K	4.12M	280M	-
Short Term Debt Repaid, Total	-2.06B	-439M	-467M	-	-4.4B
Long-Term Debt Repaid, Total	-10.28M	-652M	-720M	-815M	-2.09B
Total Debt Repaid	-2.07B	-1.09B	-1.19B	-815M	-6.49B
Repurchase of Common Stock	-	-	-	-	-810M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-688M	-765M	-871M	-746M	-361M
Cash from Financing	-1.19B	-1.86B	-2.05B	-1.28B	-7.67B
Miscellaneous Cash Flow Adjustments	-	-	-	-	-10K
Net Change in Cash	-77.31M	-2.28M	22.26M	-5.84M	929M
Supplemental Items
Cash Interest Paid	788M	795M	871M	746M	361M
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-492M	260M	968M	-171M	5.25B
Unlevered Free Cash Flow	-54.91M	777M	1.53B	311M	5.26B
Change In Net Working Capital	1.01B	-519M	-638M	-678M	-5.85B
Net Debt Issued / Repaid	-506M	-1.09B	-1.18B	-535M	-6.49B

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	2.66	-0.14	2.64	-2.61	-5.21
Return on Total Capital	3.25	-0.17	3.28	-3.41	-6.56
Return On Equity %	2.33	-2.25	0.47	-11.23	-7.46
Return on Common Equity	2.33	-2.25	0.47	-11.23	-7.46
Margin Analysis
Gross Profit Margin %	26.71	23.92	28.61	16.88	-
SG&A Margin	4.57	5.22	5.14	5.9	-
EBITDA Margin %	9.5	3.54	9.09	-1.56	-
EBITA Margin %	6.56	0.25	6.16	-4.57	-
EBIT Margin %	6.09	-0.34	5.49	-5.3	-
Income From Continuing Operations Margin %	1.5	-1.59	0.3	-6.81	-
Net Income Margin %	1.5	-1.59	0.3	-6.81	-
Net Avail. For Common Margin %	1.5	-1.59	0.3	-6.81	-
Normalized Net Income Margin	0.92	-3.4	0.67	-6.04	-
Levered Free Cash Flow Margin	-2.95	1.7	5.75	-1.02	-
Unlevered Free Cash Flow Margin	-0.33	5.1	9.07	1.86	-
Asset Turnover
Asset Turnover	0.7	0.67	0.77	0.79	-
Fixed Assets Turnover	2.09	2.09	2.5	2.59	-
Receivables Turnover (Average Receivables)	4.06	4.19	5.11	4.61	-
Inventory Turnover (Average Inventory)	1.78	1.6	1.59	1.83	-
Short Term Liquidity
Current Ratio	1.35	1.38	1.32	1.21	9.59
Quick Ratio	0.53	0.41	0.45	0.4	6.56
Operating Cash Flow to Current Liabilities	0.09	0.15	0.23	0.17	-11.58
Days Sales Outstanding (Average Receivables)	89.87	87.03	71.59	79.2	-
Days Outstanding Inventory (Average Inventory)	205.4	228.7	229.55	199.63	-
Average Days Payable Outstanding	101.76	108.51	108.34	115.6	-
Cash Conversion Cycle (Average Days)	193.5	207.22	192.79	163.23	-
Long Term Solvency
Total Debt/Equity	79.04	70.81	59.44	60.87	-
Total Debt / Total Capital	44.15	41.46	37.28	37.84	-
LT Debt/Equity	26.76	21.27	13.12	6.29	-
Long-Term Debt / Total Capital	14.94	12.45	8.23	3.91	-
Total Liabilities / Total Assets	54.5	51.37	51.2	53.3	6.32
EBIT / Interest Expense	1.45	-0.06	1.03	-1.15	-757.07
EBITDA / Interest Expense	2.27	0.65	1.71	-0.34	-601.95
(EBITDA - Capex) / Interest Expense	1.91	0.29	1.38	-0.91	-685.44
Total Debt / EBITDA	5.42	13.97	4.15	-22.32	-
Net Debt / EBITDA	5.31	13.64	4.02	-21.56	1.41
Total Debt / (EBITDA - Capex)	6.44	31.56	5.14	-8.33	-
Net Debt / (EBITDA - Capex)	6.3	30.81	4.97	-8.05	1.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.13	-8.7	10.53	-0.84	-
Gross Profit, 1 Yr. Growth %	15.41	-18.24	32.23	-39.38	-
EBITDA, 1 Yr. Growth %	43.83	-65.98	183.8	-116.98	-243.63
EBITA, 1 Yr. Growth %	76.79	-96.5	2.6K	-173.33	-1.04K
EBIT, 1 Yr. Growth %	103.23	-105.09	-1.89K	-195.29	14.15K
Earnings From Cont. Operations, 1 Yr. Growth %	-134.19	-196.55	-120.66	-2.38K	-8.33K
Net Income, 1 Yr. Growth %	-134.19	-196.55	-120.66	-2.38K	157.64
Normalized Net Income, 1 Yr. Growth %	-141.56	-436.16	-121.81	-993.11	-13.61K
Diluted EPS Before Extra, 1 Yr. Growth %	-134.15	-196.7	-120.37	-2.4K	-8.85K
Accounts Receivable, 1 Yr. Growth %	19.25	-37.45	35.62	-8.89	-
Inventory, 1 Yr. Growth %	10.06	1.42	6.15	-4.41	-99.91
Net Property, Plant and Equip., 1 Yr. Growth %	-8.05	-9.77	-4.98	-3.46	-83.67
Total Assets, 1 Yr. Growth %	0.11	-8.43	0.08	-6.56	-69.64
Tangible Book Value, 1 Yr. Growth %	2.07	-2.83	0.16	-11.53	-35.4
Common Equity, 1 Yr. Growth %	2.44	-2.14	0.44	-10.58	-39.1
Cash From Operations, 1 Yr. Growth %	344.38	40.68	68.11	-24.59	-305.81
Capital Expenditures, 1 Yr. Growth %	-20.07	20.38	-2.15	48.89	-71.97
Levered Free Cash Flow, 1 Yr. Growth %	-123.53	-152.75	272.94	-117.61	512.02
Unlevered Free Cash Flow, 1 Yr. Growth %	-102.09	-1.52K	96.66	-79.72	512.12
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-16.02	-0.64	0.46	4.7	-
Gross Profit, 2 Yr. CAGR %	-6.31	-2.86	3.98	-12.05	-
EBITDA, 2 Yr. CAGR %	-15.12	-30.05	-1.74	-30.47	-24.09
EBITA, 2 Yr. CAGR %	-20.35	-75.11	-2.69	346.03	1.32
EBIT, 2 Yr. CAGR %	-20.15	-67.83	-4.64	313.58	9.49
Earnings From Cont. Operations, 2 Yr. CAGR %	-11.24	-42.55	-55.34	116.81	238.83
Net Income, 2 Yr. CAGR %	-11.24	-42.55	-55.34	116.81	665.75
Normalized Net Income, 2 Yr. CAGR %	-18.55	18.2	-14.37	39.57	178.33
Diluted EPS Before Extra, 2 Yr. CAGR %	-11.24	-42.53	-55.62	116.67	245.39
Accounts Receivable, 2 Yr. CAGR %	6.26	-13.63	-7.89	11.16	-
Inventory, 2 Yr. CAGR %	-15.41	5.65	3.76	0.73	-97.14
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.71	-8.91	-7.4	-4.22	-60.3
Total Assets, 2 Yr. CAGR %	-4.72	-4.26	-4.27	-3.3	-46.74
Tangible Book Value, 2 Yr. CAGR %	-2.4	-0.41	-1.35	-5.87	-24.4
Common Equity, 2 Yr. CAGR %	-2.15	0.12	-0.86	-5.23	-26.2
Cash From Operations, 2 Yr. CAGR %	-42.26	150.03	53.79	12.6	24.58
Capital Expenditures, 2 Yr. CAGR %	-32.48	-1.91	8.54	20.7	-35.4
Levered Free Cash Flow, 2 Yr. CAGR %	-38.54	-64.77	40.26	-18.83	132.64
Unlevered Free Cash Flow, 2 Yr. CAGR %	-82.89	-45.62	427.55	-36.78	85.28
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-15.67	-13.65	2.95	0.03	-
Gross Profit, 3 Yr. CAGR %	-7.61	-10.47	7.66	-14.16	-
EBITDA, 3 Yr. CAGR %	-15.68	-37.42	11.57	-45.21	17.93
EBITA, 3 Yr. CAGR %	-20.4	-71.88	18.74	-11.32	203.14
EBIT, 3 Yr. CAGR %	-20.37	-68.1	22.71	-4.51	178.14
Earnings From Cont. Operations, 3 Yr. CAGR %	-19.27	-8.71	-59.15	65.57	33.35
Net Income, 3 Yr. CAGR %	-19.27	-8.71	-59.15	65.57	129.65
Normalized Net Income, 3 Yr. CAGR %	-25.24	30.65	-32.71	87.09	19.11
Diluted EPS Before Extra, 3 Yr. CAGR %	-19.24	-8.67	-59.33	65.58	34.44
Accounts Receivable, 3 Yr. CAGR %	-7.17	-10.94	0.39	-8.23	-
Inventory, 3 Yr. CAGR %	-7.72	-10.14	5.82	0.96	-90.47
Net Property, Plant and Equip., 3 Yr. CAGR %	-4.74	-7.08	-7.62	-6.11	-46.89
Total Assets, 3 Yr. CAGR %	-4.03	-5.97	-2.83	-5.04	-34.27
Tangible Book Value, 3 Yr. CAGR %	-0.66	-2.55	-0.22	-4.87	-16.97
Common Equity, 3 Yr. CAGR %	-0.52	-2.14	0.23	-4.21	-18.22
Cash From Operations, 3 Yr. CAGR %	-26.5	-22.3	119.04	21.27	37.67
Capital Expenditures, 3 Yr. CAGR %	-13.16	-18.12	-1.99	20.6	-25.81
Levered Free Cash Flow, 3 Yr. CAGR %	-17.39	-41.59	-22.64	-29.69	172.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	-66.2	-25.46	-16.53	78.17	89.11
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.3	-4.08	-9.56	-6.73	-
Gross Profit, 5 Yr. CAGR %	-1.85	-6.47	-3.14	-11.1	-
EBITDA, 5 Yr. CAGR %	-6.73	-25.6	-10.36	-34.73	-4.3
EBITA, 5 Yr. CAGR %	-9.34	-54.17	-13.74	-15.05	11.54
EBIT, 5 Yr. CAGR %	-8.96	-50.4	-14.42	-11.1	17.36
Earnings From Cont. Operations, 5 Yr. CAGR %	-14.66	-14.29	-36.29	29.03	-4.78
Net Income, 5 Yr. CAGR %	-14.66	-14.29	-36.29	29.03	31.94
Normalized Net Income, 5 Yr. CAGR %	-13.8	5.88	-21.07	34.15	18.74
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.66	-14.25	-36.44	29.03	-4.3
Accounts Receivable, 5 Yr. CAGR %	-2.21	-14.5	-7.46	-2.69	-
Inventory, 5 Yr. CAGR %	-3.34	-3.17	-3.29	-5.94	-75.05
Net Property, Plant and Equip., 5 Yr. CAGR %	-3.74	-5.29	-5.81	-5.95	-34.1
Total Assets, 5 Yr. CAGR %	-1.52	-4.28	-4.13	-4.91	-23.6
Tangible Book Value, 5 Yr. CAGR %	1.94	0.05	-0.94	-3.89	-10.7
Common Equity, 5 Yr. CAGR %	1.56	0.11	-0.66	-3.39	-11.32
Cash From Operations, 5 Yr. CAGR %	-13.72	15.45	-1.25	-9.88	74.78
Capital Expenditures, 5 Yr. CAGR %	-14.1	-1.95	-5.06	-4.37	-17.04
Levered Free Cash Flow, 5 Yr. CAGR %	5.43	-19.1	2.09	-33.37	20.23
Unlevered Free Cash Flow, 5 Yr. CAGR %	-43.63	31.61	1.45	-30.21	14.87
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-